28/05/2024  12:09:36 Chg. +0.160 Volume Bid12:09:36 Demandez à12:09:36 Capitalisation boursière Dividende Y. Rapport P/E
7.660EUR +2.13% -
Chiffrre d'affaires: -
7.660Bid taille: - 7.755Ask la taille: - 2.82 Mrd.EUR - -

Description de l'entreprise

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
 

Conseil d'administration & Conseil de surveillance

PDG
Gustaf Salford
Conseil d'administration
Tobias Hägglöv, Jonas Bolander, Anna Conneryd Lundgren, Habib Nehme, Maurits Wolleswinkel, John Lapré
Conseil de surveillance
Laurent Leksell, Birgitta Stymne Göransson, Caroline Leksell Cooke, Cecilia Wikström, Jan Secher, Johan Malmquist, Wolfgang Reim, Kelly Londy
 

Données de l'entreprise

Nom: Elekta AB
Adresse: Kungstensgatan 18,S-103 93 Stockholm
Téléphone: +46-8-587-254-00
Fax: +46-8-587-255-00
Courriel: info@elekta.com
Internet: www.elekta.com/
Industrie: Healthcare
Secteur: Medical Products
Sous-secteur: Advanced Medical Devices
Fin de l'exercice financier: 30/04
Flotte libre: -
IPO date: -

Relations avec les investisseurs

Nom: Cecilia Ketels
Téléphone IR: +46-707-6381-25
IR-Fax: -
E-mail IR: cecilia.ketels@elekta.com

Calendrier de l'entreprise

CW 23 | 05/06/2024 4th Quarter/Annual Report
 

Principaux actionnaires

Autres
 
59.02%
Fourth Swedish National Pension Fund
 
9.08%
Laurent Leksell with company
 
5.72%
T. Rowe Price
 
4.55%
Nordea Funds
 
4.43%
SEB Funds
 
3.40%
Vanguard
 
3.31%
AMF Pension & Funds
 
2.82%
Handelsbanken Funds
 
2.80%
Autres
 
4.87%